|
|
.
See Category: Diseases of the musculoskeletal system and connective tissue
See Header: Rheumatoid arthritis w involvement of oth organs and systems
ICD-10 (CM) Code and Descriptor
|
M05.60 |
Rheumatoid arthritis of unspecified site with involvement of other organs and systems
|
M0560 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 26.52%
|
26.59%
|
12.67%
|
8.64%
|
6.74%
|
5.49%
|
4.25%
|
3.30%
|
1.25%
|
1.32%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for M05.60*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
138
|
139
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
125
|
125
|
|
96413
|
CHEMO IV INFUSION 1 HR |
92
|
92
|
|
80053
|
COMPREHEN METABOLIC PANEL |
87
|
87
|
|
97110
|
THERAPEUTIC EXERCISES |
76
|
106
|
|
96415
|
CHEMO IV INFUSION ADDL HR |
72
|
104
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
66
|
66
|
|
J3262
|
TOCILIZUMAB INJECTION |
63
|
12,040
|
|
97530
|
THERAPEUTIC ACTIVITIES |
60
|
93
|
|
86140
|
C-REACTIVE PROTEIN |
56
|
56
|
|
86738
|
MYCOPLASMA ANTIBODY |
52
|
52
|
|
86635
|
COCCIDIOIDES ANTIBODY |
51
|
52
|
|
86632
|
CHLAMYDIA IGM ANTIBODY |
50
|
75
|
|
86631
|
CHLAMYDIA ANTIBODY |
50
|
150
|
|
86606
|
ASPERGILLUS ANTIBODY |
49
|
75
|
|
85652
|
RBC SED RATE AUTOMATED |
48
|
48
|
|
86431
|
RHEUMATOID FACTOR QUANT |
39
|
39
|
|
97140
|
MANUAL THERAPY 1/> REGIONS |
38
|
41
|
|
86235
|
NUCLEAR ANTIGEN ANTIBODY |
37
|
141
|
|
J1745
|
INFLIXIMAB NOT BIOSIMIL 10MG |
37
|
1,049
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
M05.60 related to the following DRG Codes:
545-547
|
